Welcome, Guest. Please login or register.
April 13, 2024, 11:55:11 am

Login with username, password and session length

  • Total Members: 6307
  • Latest: golfer
  • Total Posts: 55125
  • Total Topics: 4851
  • Online Today: 98
  • Online Ever: 1314
  • (June 22, 2016, 05:23:42 am)
Users Online
Users: 0
Guests: 32
Total: 32


Welcome to the Hep Forums, a round-the-clock discussion area for people who have Fatty Liver Disease, Hepatitis B, C or a co-infection, their friends and family and others with questions about hepatitis and liver health. Check in frequently to read what others have to say, post your comments, and hopefully learn more about how you can reach your own health goals.

Privacy Warning: Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.
  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.
  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.
  • Product advertisement (including links); banners; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from the Hep Forum Moderators.
Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: Treating Hepatitis C Reduces Risk of Cardiovascular Disease  (Read 5328 times)

0 Members and 1 Guest are viewing this topic.

Offline Hep Editors

  • Member
  • Posts: 784
    • Hep Mag
Treating Hepatitis C Reduces Risk of Cardiovascular Disease
« on: January 23, 2019, 10:45:27 am »
People with hepatitis C virus (HCV) have a lower risk of cardiovascular disease (CVD) if they receive treatment for the virus, in particular if that treatment is with direct-acting antivirals (DAAs) rather than interferon-based regimens, MedPage Today reports.

Publishing their findings in Gastroenterology, researchers reviewed data from the Electronically Retrieved Cohort of HCV-infected Veterans and identified 242,689 with hep C. Among them, 4,436 were treated with interferon-based regimens while 12,667 received DAA regimens. The study authors drew upon the wider cohort of people with HCV to match the treated individuals according to age, race, sex and other baseline characteristics.

For more...


© 2024 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.